How to Order Your Own Lab Tests

Direct-to-consumer lab testing removes the gatekeeper—order blood work yourself, get results in days, share with your provider. Here’s how the system actually works and what to watch for.

Why Direct-to-Consumer Lab Testing Exists

The traditional model works like this: you call your physician’s office, schedule an appointment, see the doctor, they order tests, you wait for insurance approval, you get blood drawn at their preferred lab, your results go back to the doctor’s office, you wait for an interpretation call that may or may not happen, and you finally understand your numbers—three weeks after your initial appointment.

For many people engaged in self-directed research protocols (especially with peptides), this model breaks down. Your physician may not be familiar with your protocol. They may decline to order tests because they consider the protocol outside standard practice. Or they may order tests but not monitor the specific markers you care about. The friction is real, and it’s intentional: the traditional system reserves medical ordering authority for licensed physicians.

Direct-to-consumer lab services exist because that friction creates a market. Instead of asking permission, you order the tests yourself, pay out of pocket, and get results in 3–7 business days. The blood draw still happens at a certified lab facility (Quest, LabCorp, or independent phlebotomy), and the analysis still happens in a CLIA-certified lab. The difference is that you, not a physician, initiated the order.

This is legal in most U.S. states (with notable exceptions we’ll cover). It does not, however, replace physician interpretation. Ordering is the easy part. Understanding what your results mean—in the context of your age, sex, medications, protocol, and health history—requires clinical judgment. DTC testing gives you the data. A qualified provider gives you meaning.

How DTC Lab Testing Actually Works

The workflow is straightforward and worth walking through step-by-step because it’s faster and less opaque than most people assume.

Step 1: Choose a Lab Service Platform

You navigate to a DTC lab platform’s website (more on which platforms exist in the next section). You create an account, verify your identity (usually just name, address, and date of birth), and confirm you’re in a state where DTC ordering is permitted. Most platforms do this automatically by checking your ZIP code.

Step 2: Select Tests or Panels

You browse the lab’s test menu. Most platforms let you either buy pre-built panels (a bundled collection of tests at a discount) or cherry-pick individual tests. A “complete metabolic panel” (CMP) comes as one SKU. But you can also add IGF-1, testosterone, or estradiol as standalone orders. Some platforms let you build custom panels and save them for future use.

Step 3: Pay

DTC lab tests are out-of-pocket expenses. Insurance rarely covers them unless you have a physician’s order (which defeats the purpose of DTC). However, most lab test costs are HSA/FSA-eligible, meaning you can pay with tax-advantaged healthcare savings. Typical baseline panels run $150–$400 depending on what’s included and which platform you use. Expect to pay more than you would with insurance, but typically less than the list price a physician’s office would charge.

Step 4: Go to a Draw Site

After you order, you receive a laboratory requisition (either emailed or accessible in the platform’s patient portal). You take this requisition to any of the platform’s partner draw sites. Most major DTC platforms partner with either Quest or LabCorp, so you’ll usually find a location within 10 miles of your home. You walk in, hand them your requisition, they draw your blood, and you’re done in 10 minutes. Fasting draw appointments are preferred for metabolic panels and should be booked in the morning.

Step 5: Receive Results Online

After the blood draw, the lab processes your samples. Turnaround time is typically 3–7 business days. You receive an email notification when your results are ready, and you access them directly in the platform’s patient portal. Results are presented with reference ranges, usually with automatic flagging of values outside the normal range.

Step 6: Share Results With Your Provider

You download your results as a PDF (every platform offers this) and share them with your physician or telehealth provider. Most telehealth platforms have patient portals where you can upload outside lab work. Some providers will review and interpret; others may order confirmatory tests if they have concern about data quality or accuracy. The results are entirely yours to interpret with professional guidance.

Evaluating Lab Service Platforms

Not all DTC lab platforms are equal. The differences matter, especially if you’re planning regular monitoring on a protocol. Here’s what to evaluate:

Lab Partnership and Draw Site Availability

The best DTC platforms partner with either Quest Diagnostics or LabCorp—the two largest clinical lab networks in the U.S. This means draw sites everywhere and fast processing. Some platforms use independent phlebotomy networks, which can be cheaper but offer fewer locations and potentially slower turnaround. Check whether the platform has a draw site within a reasonable distance before signing up.

Test Menu Breadth

You need a platform that offers tests relevant to your protocol. If you’re researching GH secretagogues, you need IGF-1 and IGFBP-3. If you’re monitoring GLP-1 effects, you need lipase, fasting glucose, and HbA1c. Some platforms focus on wellness and offer limited hormone panels. Others are more comprehensive. Cross-reference against our panel recommendations below.

Pricing Transparency and Panel Cost Structure

Pricing varies widely, and sometimes building a custom panel is cheaper than buying a pre-built one. A platform might charge $300 for a “comprehensive hormone panel” but only $200 if you select testosterone, estradiol, SHBG, LH, and FSH individually. Always check both routes. Also note whether the platform charges a membership or subscription fee or if tests are purely à la carte.

Turnaround Time

Most major platforms deliver results in 3–7 business days. Some offer “rush” processing for an extra fee. If you’re monitoring a protocol closely, faster turnaround is worth paying for. Platforms that use only independent phlebotomy may take longer because samples go through extra routing steps.

Result Presentation Quality

Your results should come with reference ranges clearly marked, automatic flagging of out-of-range values, and the ability to download a PDF. Better platforms provide historical comparisons (showing your trend over time) and trend graphs. Some platforms integrate with wearables or other health apps. This matters because you’ll be looking at these results repeatedly, and good presentation makes patterns obvious.

CLIA and CAP Certification

This is non-negotiable. Any lab that processes your samples must be CLIA-certified (Clinical Laboratory Improvement Amendments—a federal standard) and ideally CAP-accredited (College of American Pathologists—a voluntary higher standard). Look for this certification on the platform’s website. If it’s not visible, don’t use them. You can also verify CLIA certification via the CMS database.

HSA/FSA Eligibility

Most DTC lab tests are eligible Health Savings Account (HSA) and Flexible Spending Account (FSA) expenses. This is a significant tax advantage if you have these accounts. However, not all platforms process HSA/FSA payments, and some require you to submit receipts to your account administrator for reimbursement. If you have an HSA or FSA, verify that your chosen platform accepts direct payment from your account or provides clear documentation for reimbursement claims.

Recommended Panels by Protocol Type

If you’ve read our biomarkers guide (forthcoming), you know what to test. Here’s how to actually order what’s described—with realistic pricing and panel options.

Universal Baseline Panel (~$150–$300)

Everyone should have this before starting any protocol. Order as a pre-built panel if available, or build it yourself:

• Complete metabolic panel (CMP) — electrolytes, kidney function, liver function, fasting glucose
• Complete blood count (CBC) — red cell, white cell, hemoglobin, platelet counts
• Lipid panel — total cholesterol, HDL, LDL, triglycerides
• Hemoglobin A1c — 3-month glucose average
• Fasting insulin — baseline insulin sensitivity
• Thyroid panel (TSH, free T4) — thyroid baseline
• High-sensitivity C-reactive protein (hsCRP) — systemic inflammation marker

This is your safety baseline. Order it before starting anything, and reorder it annually or after any protocol changes.

GH Secretagogue Add-On (~$50–$100)

If you’re using CJC-1295 (no DAC) + ipamorelin or similar GH-releasing protocols, add these tests to your baseline panel:

• IGF-1 — the integrated marker of growth hormone secretion
• IGFBP-3 — IGF-1 binding protein; provides context to raw IGF-1 value

If you’re protocol monitoring, you’ll retest these every 4–8 weeks. The cost of re-testing just IGF-1 and IGFBP-3 is usually under $80, making it a cost-effective way to track protocol efficacy.

GLP-1 / Metabolic Add-On (~$30–$60)

If you’re using semaglutide, tirzepatide, or other GLP-1 agonists, augment your baseline with:

• Lipase — pancreatic inflammation marker; critical for GLP-1 safety monitoring
• Amylase — additional pancreatic marker
• Liver function tests (if not included in CMP) — ALT, AST, bilirubin

If your baseline CMP doesn’t include liver tests, add them. GLP-1 agonists are metabolized hepatically, so liver baseline matters. Retest lipase and amylase at 4 weeks and 12 weeks on any GLP-1 protocol.

Hormonal Panel Add-On (~$100–$200)

If you’re researching hormonal effects of peptides or managing hormone-related protocols, add a comprehensive hormone panel:

• Testosterone (total and free) — baseline androgens
• Estradiol (sensitive or LC-MS) — baseline estrogens
• SHBG — sex hormone-binding globulin; context for free hormone ratios
• LH and FSH — gonadotropins; valuable for protocol assessment
• Prolactin — baseline; some peptides affect prolactin

This panel is expensive as a standalone but cost-effective if ordered as part of a larger test battery. Retest every 8–12 weeks if actively monitoring protocol effects.

Full Comprehensive Panel (~$300–$500)

If you want everything—baseline safety, GH secretagogue markers, metabolic markers, and hormonal markers—combine all above. This is the “maximum information” approach. Most DTC platforms offer this as a single bundled panel at a small discount relative to ordering tests individually. Run this once before starting any protocol, then return to targeted re-testing based on which peptides you’re using. Budget $400–$500 for the initial comprehensive, then $100–$200 per follow-up based on which specific tests you actually need to retest.

The Fasting and Timing Rules

When you get your blood drawn matters. Timing affects values more than most people realize, and mistakes here corrupt your baseline or your comparisons.

Fasting Requirements

Metabolic panels (CMP, glucose, lipids, fasting insulin, hsCRP) require a 10–12 hour fast. This means no food or beverages except water after 8 PM the night before. Morning draws (8–10 AM) are ideal. Water is fine and encouraged (being hydrated makes veins more accessible). Black coffee is controversial; some labs say it doesn’t affect metabolic panels, others recommend avoiding it. If you want the cleanest results for comparison purposes, skip coffee on the morning of your draw.

IGF-1 and IGFBP-3 are NOT significantly fasting-sensitive, but you should fast anyway for consistency. The goal is to make your baseline repeatable. If your next IGF-1 retest is also fasted, you’re comparing apples to apples.

Hormone panels (testosterone, estradiol, SHBG, LH, FSH, prolactin) have mild fasting-sensitivity but aren’t strictly required to be fasted. However, consistency matters more than the fasting itself. If your baseline test was done fasted, retest fasted. If non-fasted, keep it non-fasted.

Diurnal Variation and Draw Timing

Cortisol and testosterone are highest in early morning and decline throughout the day. If you draw at 8 AM, you’ll get a different value than if you draw at 2 PM—even from the same person on the same day. For hormone panels, consistency in draw time is more important than absolute timing. If your baseline testosterone was drawn at 8:30 AM, retest at 8:30 AM. If your baseline was at 10 AM, retest at 10 AM. This removes diurnal variation from your comparison.

For the absolute best testosterone comparison, draw between 8–10 AM on all occasions. This is when levels are highest and most stable.

Protocol-Relative Timing

If you’re actively on a peptide protocol, time your draw relative to your dosing schedule. For most peptides, you want trough levels—meaning you draw before your next dose, not shortly after. This is true for IGF-1 (draw in morning before any injection), testosterone (if using protocols that affect it), and metabolic markers.

The exception: if you’re specifically investigating acute effects of a peptide, you might draw at peak time (1–2 hours post-injection for subcutaneous peptides). But for baseline monitoring and protocol safety assessment, trough (pre-dose) is standard.

GH Itself Is Pulsatile

One critical note: do not order a direct GH test (serum growth hormone). GH is pulsatile—it spikes rapidly after secretion and is undetectable most of the time. A single draw tells you almost nothing. This is why IGF-1 exists: it’s the integrated marker of GH secretion over the preceding days. If someone suggests you test GH directly, ask them why. The answer should be “we’re checking for a GH-secreting tumor,” which is a clinical diagnosis context, not a protocol monitoring context.

Understanding Your Results

Your lab results arrive with reference ranges and flags. Understanding what those actually mean is where most people get confused—and where professional interpretation becomes essential.

Reference Ranges Are Population Norms, Not Individual Targets

A reference range is the middle 95% of values from a large healthy population. When you see “Normal: 70–100 mg/dL” for fasting glucose, that doesn’t mean 70 is optimal and 100 is alarming. It means that’s where most healthy people fall. Your individual target might be different based on your age, sex, metabolic health, and protocol goals.

Example: fasting glucose is “normal” up to 100 mg/dL, but if yours jumps from 88 to 98 after starting a GLP-1 protocol, that might indicate insufficient dosing or metabolic stress, even though both values are technically in range.

Flags (H and L) Indicate Out-of-Range, Not Necessarily Alarming

When a value gets flagged “H” (high) or “L” (low), it simply means it’s outside the reference range. This is useful data, but it’s not equivalent to “emergency.” A hemoglobin of 13.5 might be flagged low for a man (normal: 13.5–17.5 g/dL) but is completely unremarkable. The flag is a signal to look closer, not a cause for panic.

Baseline vs. Trend Is More Informative Than Any Single Result

The most useful comparison is your own prior result. If your IGF-1 was 150 ng/mL at baseline and is now 280 ng/mL after 8 weeks on CJC-1295 + ipamorelin, you know the protocol is working. Comparison to reference ranges is secondary. Your own trend tells you about your response.

This is why consistent timing (same time of day, same fasting status) matters: it lets you trust your own trend. If you retest at different times of day or fasting status, you’ve added noise and lost the signal.

When Results Warrant Genuine Concern

Some results are actually alarming and warrant immediate attention. Critical values that demand a provider call:

• Potassium <3.0 or >6.0 mEq/L (cardiac risk)
• Glucose <50 or >500 mg/dL (hypoglycemia or hyperglycemic crisis)
• Lipase >500 U/L (suggests acute pancreatitis)
• ALT or AST >300 U/L (acute liver injury)
• Creatinine >2.5 mg/dL (suggests acute kidney injury)
• Troponin detectable (cardiac damage)
• White blood cell count <2.5 or >30 K/μL (infection risk or leukemia)

If any of these appear in your results, contact your provider immediately. Don’t wait. These are genuinely concerning values.

The Case for Professional Interpretation

You can learn to read your own lab work. But here’s what a skilled provider brings: clinical context. They know your age, sex, medications, comorbidities, and goals. They can distinguish a benign variation from a trend that matters. They know which patterns warrant further investigation and which are expected. They can integrate one lab result with others. You may be able to see that your testosterone is 650 ng/dL, but a provider can tell you whether that’s optimal for your goals, whether it warrants monitoring, and whether it fits your protocol. This is why sharing results with a qualified provider—telehealth or otherwise—is essential to the whole process.

Using Lab Results With Your Telehealth Provider

One of DTC testing’s biggest strengths is integration with telemedicine. Most telehealth platforms now accept outside lab work. Here’s how to navigate this process.

Getting Your Results to Your Provider

Every DTC platform lets you download results as a PDF. Take that PDF and upload it to your telehealth provider’s patient portal, or email it directly to your provider if they don’t have a portal. Most modern telehealth services (including many direct-to-consumer peptide clinics) expect patients to bring their own lab work. It’s normal. If your provider refuses to review outside labs, that’s a red flag about their practice (see our telehealth provider guide, forthcoming).

Sharing Is Legal and Standard

Results from DTC labs are your property. You can share them with any provider you choose. Some old-school physician practices act like results “belong” to them because they ordered the test. This is outdated thinking. Your results belong to you. Share freely with any provider you work with.

Using Your Baseline to Hold Providers Accountable

Having your own baseline is powerful. If a provider recommends a protocol but never orders follow-up labs, you have baseline data that shows you weren’t monitoring. If a provider promises specific results but your markers move in the opposite direction, your baseline lets you objectively assess that. Providers who take protocol monitoring seriously will review your baseline, set clear goals for your follow-up tests, and track those goals over time.

When to Retest

There’s no universal schedule, but here’s a reasonable framework: retest metabolic and safety markers (CMP, lipids, liver enzymes, kidney function) every 3–6 months while actively on a protocol. Retest protocol-specific markers (IGF-1 for GH secretagogues, lipase for GLP-1) every 4–8 weeks if optimizing, then every 3 months once stable. Annual comprehensive retesting is reasonable maintenance even if you’re between protocols. Your provider should guide this, but your baseline data makes the conversation easier and more data-driven.

State-by-State Restrictions

DTC lab testing is legal in most U.S. states. A few states restrict it, and a couple have workarounds.

New York

New York requires a physician’s order for any lab test. DTC ordering is not permitted. Workaround: some DTC platforms partner with physician networks that will order tests on your behalf (you answer a brief questionnaire, a physician in their network reviews it, and they place the order). The cost is higher, and the process is slower, but it’s legal. Check whether your chosen platform offers New York-compliant ordering before signing up.

New Jersey

New Jersey has similar restrictions: lab tests must be ordered by a physician. Some DTC platforms offer physician-intermediary services for New Jersey residents as well.

Rhode Island

Rhode Island restricts DTC access but does allow some tests. The restrictions are complex and depend on the specific test. Some major platforms don’t service Rhode Island at all because the regulatory burden isn’t worth it.

Maryland

Maryland has some restrictions on specific tests but permits most standard panels. Check your platform’s Maryland policy before ordering if you’re in that state.

All Other States

If you’re not in NY, NJ, RI, or have specific concerns about MD, DTC ordering is generally unrestricted. You can order tests yourself without a physician’s permission. Most major platforms will verify your state at checkout and prevent you from ordering if you’re in a restricted area or will offer a physician-intermediary service if available. Don’t worry about state restrictions unless you’re in one of the four states listed above—and even then, there are workarounds.

Frequently Asked Questions

Is ordering your own lab tests legal?

Yes, in most U.S. states. You have the legal right to order lab tests directly from most DTC platforms without a physician’s authorization. New York, New Jersey, and Rhode Island restrict this and require a physician’s order (though many DTC platforms partner with physician networks to offer workarounds). Check your state regulations or simply try to order—if you’re in a restricted state, the platform will let you know at checkout.

Will my insurance cover direct-to-consumer lab tests?

Almost never. Insurance covers lab tests when a physician orders them as part of patient care. DTC tests are private-pay because no physician is involved in the ordering. You’ll pay out of pocket—typically $150–$400 for a baseline panel, less for targeted retesting. This is why HSA/FSA eligibility matters (see next question).

Can I use HSA or FSA funds for DTC lab tests?

Yes. Most DTC lab tests are HSA/FSA-eligible health expenses. You can pay directly with your HSA or FSA card on some platforms, or pay out of pocket and submit receipts to your account administrator for reimbursement. Check with your specific platform about how they process HSA/FSA payments, and verify with your account administrator about reimbursement eligibility. This is a significant tax advantage if you have these accounts—it effectively reduces your cost by 20–30% depending on your tax bracket.

How often should I retest while on a peptide protocol?

It depends on which peptides and which markers. For safety (metabolic panel, liver function, kidney function, CBC), retest every 3–6 months once you’re stable on a protocol. For protocol-specific markers (IGF-1 for GH secretagogues, lipase for GLP-1 agonists), retest every 4–8 weeks if you’re optimizing dosing, then every 3 months once stable. Annual comprehensive retesting is reasonable maintenance. Your provider should guide this, but frequent retesting of all panels is expensive and unnecessary—target your retesting to what actually matters for your protocol.

What if my results are abnormal—what do I do?

First, don’t panic. Most flagged values are benign variations, not emergencies. Second, check for critical values that warrant immediate physician contact: potassium <3 or >6, glucose <50 or >500, lipase >500, ALT/AST >300, creatinine >2.5, detectable troponin, or WBC <2.5 or >30. If you have any of those, contact your provider immediately. For everything else, share your results with your telehealth provider and discuss context. A single abnormal value often means nothing. A trend over time means something. Your provider can distinguish the difference.

Can I order the same tests my doctor would order?

Almost always yes. Most standard clinical panels are available through DTC platforms: metabolic panels, CBC, lipid panels, thyroid panels, hormone panels, specialized markers like IGF-1 or hsCRP. The tests are the same, the labs (Quest, LabCorp) are the same, the reference ranges are the same. The only difference is that you initiated the order instead of a physician. One caveat: some very specialized tests (genetic markers, rare disease panels) may only be available through physician-ordered networks, but standard peptide monitoring tests are all available.

Do I need to disclose my DTC lab results to my regular doctor?

You’re not legally obligated to, but it’s a good idea. If you have a primary care physician, sharing your lab results gives them a more complete picture of your health. If there’s a discrepancy (your DTC test shows something concerning), they can order confirmatory testing through their own channels. The worst outcome is hiding data from your provider—they can’t help you if they don’t know what’s happening. Be transparent: “I ordered these tests myself through a DTC lab” is fine. Most physicians understand DTC testing now and won’t object. If yours does, that tells you something about how rigid their practice is.

Related Guides

Disclaimer

This guide is for educational purposes only and does not constitute medical advice. Ordering lab tests does not replace the need for professional medical interpretation. Always share your results with a qualified healthcare provider. State regulations regarding direct-to-consumer lab testing vary; verify your state’s rules before ordering. Lab results should be interpreted in clinical context by a licensed physician or qualified healthcare provider. Neither Peptidings nor any author of this guide assumes responsibility for how this information is used.

This guide includes references to DTC lab testing platforms as part of practical guidance on how to access testing. Peptidings may have affiliate relationships with lab testing services referenced or discussed. The recommendations in this guide are based on practical utility and evidence, not affiliate status.